abelmoschus manihot
Botanicalexperimental
Abelmoschus manihot, commonly known as aibika, is a flowering plant in the family Malvaceae. It is a tropical subshrub or shrub native to the Indian subcontinent, Indochina, central and southern China, Malesia, New Guinea, and Queensland. It is cultivated and eaten as a leaf vegetable, among other uses. It was previously classified as a species of Hibiscus but is now categorized under the genus Abelmoschus. This plant is also referred to as the sunset muskmallow, sunset hibiscus, or hibiscus manihot. — Wikipedia
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
2
Earliest trial started Sep 1, 2014 (NCT02231125)
Timeline
No events for the selected filters.
Indications
Approved for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaAbelmoschus manihot ↗
Also known as
- abelmoschus manihot
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02231125 | Phase 4 | Sep 1, 2014 | Jiangsu Wuzhong Pharmaceutical Group Co., Ltd., People's Liberation Army of China |
| NCT02231138 | Phase 4 | Sep 1, 2014 | Jiangsu Wuzhong Pharmaceutical Group Co., Ltd., People's Liberation Army of China |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. | For profit | 2 | 0 | 1 | 2014 |
| People's Liberation Army of China | Government | 2 | 2 | 1 | 2014 |
2 organizations
Page 1 / 1